- Generic Triumeq 50mg/600mg/300mg tablets
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Generic Triumeq 50mg/600mg/300mg tablets | Start Date 22-09-2014 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Never Valid To Prescribe As A VMP
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- Other
Codes
- ATC Code
- J05AR13
BNF | Start Date | End Date |
---|---|---|
Current BNF 05030100 | Start Date 04-04-2022 | End Date |
Previous BNF 05030100 | Start Date 03-03-2015 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
27623511000001104 | 22-09-2014 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Abacavir sulfate | Based on Base Substance | Abacavir | 600 mg | |
Dolutegravir sodium | Based on Base Substance | Dolutegravir | 50 mg | |
Lamivudine | Based on Ingredient Substance | 300 mg |
Name
Lamivudine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
300
Strength and UOM (Dmr)
Name
Abacavir sulfate
Basis of strength description
Based on Base Substance
BOSS
Abacavir
Strength and UOM (Nmr)
600
Strength and UOM (Dmr)
Name
Dolutegravir sodium
Basis of strength description
Based on Base Substance
BOSS
Dolutegravir
Strength and UOM (Nmr)
50
Strength and UOM (Dmr)
Parent Products
-
VTMAbacavir + Lamivudine + Dolutegravir
-
VMP(Current) Generic Triumeq 50mg/600mg/300mg tab...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
30 tablet |